Stocks:
5,782
ETFs:
2,400
Exchanges:
11
Market Cap:
$53.49T
24h Vol:
$9.97B
Dominance:
AAPL:5.51%
Stocklytics Platform
Instrument logo  TMO

Thermo Fisher Scientific Inc

TMO
61 / 100
$492.921.44%$7.00

Performance History

Placeholder
Key Stats
Open$489.89
Prev. Close$485.92
EPS15.26
Dividend$1.35
Next Earnings DateJul 26, 2023
Dividend Yield %
0.29%
Market Cap
$190.45B
PE Ratio
32.30
lowhigh
Day Range489.89
495.79
52 Week Range415.60
609.84
Ratios
P/B Ratio
4.14
Revenue
$43.42B
Operating M. %
18.43%
Earnings
$5.92B
Earnings Growth %
14.70%
EBITDA Margin %
24.97%
ROE %
13.28%
EPS15.26

Score Breakdown

61vs 52. Market Avg.

All Score (61 / 100) is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

TMOMarket
Value
34
42
Quality
64
46
Ownership
94
39
Growth
58
44
Dividends
27
32

Financial Forecast

AI Price Prediction
line chart placeholder
Analyst Ratings
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$591.85
24H (%)0.04%
24H ($)$0.26
MARKET CAP$561.85B
PRICE$534.97
24H (%)-1.02%
24H ($)-$5.55
MARKET CAP$494.81B
PRICE$152.11
24H (%)0.31%
24H ($)$0.48
MARKET CAP$366.17B
PRICE$101.13
24H (%)0.94%
24H ($)$0.95
MARKET CAP$256.26B

About Thermo Fisher Scientific Inc (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

ISN
-
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Marc N. Casper
Headquarters
Waltham
Employees
130000
add Thermo Fisher Scientific Inc to watchlist

Keep an eye on Thermo Fisher Scientific Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.